Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther. 1978;23(5):547–52.
CAS
CrossRef
Google Scholar
Parker MA, Anthony JC. Should anyone be riding to glory on the now-descending limb of the crack-cocaine epidemic curve in the United States? Drug Alcohol Depend. 2014;138:225–8.
CrossRef
Google Scholar
Tsuchiya H. Anesthetic agents of plant origin: a review of phytochemicals with anesthetic activity. Molecules (Basel, Switzerland). 2017;22(8).
Google Scholar
Heal DJ, Gosden J, Smith SL. Dopamine reuptake transporter (DAT) “inverse agonism” – a novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology. 2014;87:19–40.
CAS
CrossRef
Google Scholar
Schmitt KC, Rothman RB, Reith ME. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J Pharmacol Exp Ther. 2013;346(1):2–10.
CAS
CrossRef
Google Scholar
Marquez J, Campos-Sandoval JA, Penalver A, et al. Glutamate and brain glutaminases in drug addiction. Neurochem Res. 2017;42(3):846–57.
CAS
CrossRef
Google Scholar
Castilla-Ortega E, Ladron de Guevara-Miranda D, Serrano A, et al. The impact of cocaine on adult hippocampal neurogenesis: potential neurobiological mechanisms and contributions to maladaptive cognition in cocaine addiction disorder. Biochem Pharmacol. 2017;141:100–17.
CAS
CrossRef
Google Scholar
Substance-Related and Addictive Disorders. Diagnostic and statistical manual of mental disorders.
Google Scholar
Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2013;382(9904):1564–74.
CrossRef
Google Scholar
Hughes A, Williams MR, Lipari RN, Van Horn S. State estimates of past year cocaine use among young adults: 2014 and 2015. The CBHSQ Report. Rockville: Substance Abuse and Mental Health Services Administration (US); 2013. p. 1–9.
Google Scholar
Solimini R, Rotolo MC, Pellegrini M, et al. Adulteration practices of psychoactive illicit drugs: an updated review. Curr Pharm Biotechnol. 2017;18(7):524–30.
CAS
CrossRef
Google Scholar
Dolsen MR, Harvey AG. Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994. Addiction (Abingdon, England). 2017;112(6):1104–11.
CrossRef
Google Scholar
Agargun MY, Ozbek H. Drug effects on dreaming. In: Sleep and sleep disorders: a neuropsychopharmacological approach. Boston: Springer US; 2006. p. 256–61.
CrossRef
Google Scholar
Pace-Schott EF, Stickgold R, Muzur A, et al. Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users. Psychopharmacology. 2005;179(4):873–83.
CAS
CrossRef
Google Scholar
Chen B, Wang Y, Liu X, Liu Z, Dong Y, Huang YH. Sleep regulates incubation of cocaine craving. J Neurosci Off J Soc Neurosci. 2015;35(39):13300–10.
CAS
CrossRef
Google Scholar
Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney M, Hatsukami DK. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. Addict Behav. 2005;30(6):1125–34.
CrossRef
Google Scholar
Valladares EM, Irwin MR. Polysomnographic sleep dysregulation in cocaine dependence. TheScientificWorldJOURNAL. 2007;7:213–6.
CrossRef
Google Scholar
Angarita GA, Canavan SV, Forselius E, Bessette A, Pittman B, Morgan PT. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug Alcohol Depend. 2014;134:343–7.
CAS
CrossRef
Google Scholar
Trksak GH, Bracken BK, Jensen JE, et al. Effects of sleep deprivation on brain bioenergetics, sleep, and cognitive performance in cocaine-dependent individuals. TheScientificWorldJOURNAL. 2013;2013:947879.
CrossRef
Google Scholar
Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev. 2008;12(5):381–9.
CrossRef
Google Scholar
Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9.
CrossRef
Google Scholar
Irwin MR, Bjurstrom MF, Olmstead R. Polysomnographic measures of sleep in cocaine dependence and alcohol dependence: implications for age-related loss of slow wave, stage 3 sleep. Addiction (Abingdon, England). 2016;111(6):1084–92.
CrossRef
Google Scholar
Morgan PT, Malison RT. Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence. Am J Drug Alcohol Abuse. 2008;34(6):692–702.
CrossRef
Google Scholar
Gentile TA, Simmons SJ, Barker DJ, Shaw JK, Espana RA, Muschamp JW. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol. 2018;23(1):247–55.
CAS
CrossRef
Google Scholar
Afshar M, Knapp CM, Sarid-Segal O, et al. The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. Am J Drug Alcohol Abuse. 2012;38(2):181–6.
CrossRef
Google Scholar
Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci. 2004;29(6):452–7.
PubMed
PubMed Central
Google Scholar
Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs. 2008;68(13):1803–39.
CAS
CrossRef
Google Scholar
Morgan PT, Pace-Schott E, Pittman B, Stickgold R, Malison RT. Normalizing effects of modafinil on sleep in chronic cocaine users. Am J Psychiatry. 2010;167(3):331–40.
CrossRef
Google Scholar